A Cornell-led collaboration has devised a potentially low-cost method for producing antibodies for therapeutic treatments. They've bioengineered bacteria with an overlooked enzyme that can attach ...

We've heard about potential vaccines for the coronavirus. But other drugs are also being developed. And these promising drugs are moving quickly in research - some going into their final testing ...

Dubbed the oPool + display, the method they developed could drastically accelerate antibody research and the development of ...

Antibodies are the critical targeting agents of the immune system and the crux of immune therapy and vaccine development, but ...

Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top those medicines, AbbVie has secured rights to an early-clinical drug that works ...

Detailed price information for Ginkgo Bioworks Hldgs Inc (DNA-N) from The Globe and Mail including charting and trades.

Antibodies are the critical targeting agents of the immune system and the crux of immune therapy and vaccine development, but ...

By reducing waste, improving forecasting, and strengthening payer negotiations, these technologies are helping pharmaceutical ...

An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become more cost-effective as ...